Medicare Enrolled
Dr. Toussaint Smith, MD
Cardiovascular Disease · Sugar Land, TX
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Smith from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Smith?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Smith
Dr. Toussaint Smith is a cardiovascular disease specialist in Sugar Land, TX, with 20 years of NPI registration. Based on federal Medicare data, Dr. Smith performed 5,634 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Smith received a total of $11,852 from 55 pharmaceutical and/or device companies across 600 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Smith is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 14% volume in TX
$11,852 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗5,634
Medicare services
Top 14% in TX for cardiovascular disease
Not available
Unique patients (not deduplicated)
$50
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| EKG interpretation and report A standard electrocardiogram test that records the heart's electrical activity using at least 12 leads. The service includes a professional interpretation of the results and a written report. |
1,681 | $6 | $21 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
959 | $86 | $236 |
| Echocardiogram, transthoracic An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function. |
533 | $65 | $246 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
518 | $60 | $158 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
484 | $59 | $159 |
| Regadenoson injection (Lexiscan) for heart stress test An injection of regadenoson, a medication used to stress the heart during diagnostic testing. |
212 | $42 | $119 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
179 | $10 | $48 |
| Nuclear stress test of heart muscle A nuclear medicine imaging test that evaluates blood flow to the heart muscle at rest and during stress using a special camera. |
172 | $226 | $797 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
133 | $69 | $238 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
124 | $90 | $226 |
| Technetium Tc-99m tetrofosmin diagnostic injection A diagnostic injection of Technetium Tc-99m tetrofosmin used for imaging studies. |
114 | $53 | $69 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram under physician supervision and review. |
102 | $46 | $228 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram, with physician review of the results. |
68 | $10 | $37 |
| Echocardiogram with color Doppler An ultrasound of the heart that uses color imaging to visualize blood flow, measure flow rate, and assess valve function. |
56 | $2 | $117 |
| Transesophageal echocardiogram An ultrasound of the heart performed using a probe inserted into the esophagus to obtain detailed images of heart structures and function. |
53 | $81 | $265 |
| Echocardiogram, transthoracic An ultrasound test that uses sound waves to create images of the heart's blood flow, valves, and chambers. |
53 | $14 | $178 |
| Follow-up heart ultrasound An ultrasound of the heart performed to monitor or reassess a previously identified condition or treatment progress. |
45 | $19 | $67 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
42 | $93 | $301 |
| Remote pacemaker monitoring, 90 days Remote assessment of a pacemaker system, including single, dual, multiple lead, or leadless devices, performed up to 90 days apart. |
34 | $21 | $84 |
| Continuous EKG monitoring review, 48-7 days Review and interpretation of continuous external EKG recordings lasting more than 48 hours up to 7 days. |
17 | $17 | $57 |
| External EKG monitoring, 8-15 days Continuous external electrocardiogram recording and review over a period of 8 to 15 days to monitor heart rhythm. |
17 | $19 | $59 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
14 | $109 | $316 |
| Ultrasound of head and neck blood flow, bilateral An ultrasound exam that uses sound waves to visualize and assess blood flow in the vessels of both the head and the neck. |
13 | $119 | $569 |
| Cardiac catheterization | 11 | $207 | $708 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
11.2% high complexity
14.8% medium
74.0% routine
Industry Payment Transparency
Open Payments through 2024 ↗$11,852
Total received (2018-2024)
Avg $1,693/year across 7 years
Top 28% in TX for cardiovascular disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
55
Companies
600
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,229
2023
$2,466
2022
$1,409
2021
$1,105
2020
$1,084
2019
$1,756
2018
$1,804
Payments by company (2024)
iRhythm Technologies, Inc.
$257
Novartis Pharmaceuticals Corporation
$215
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$182
Merck Sharp & Dohme LLC
$169
Janssen Pharmaceuticals, Inc
$143
Amgen Inc.
$132
Kiniksa Pharmaceuticals International, plc
$131
Boston Scientific Corporation
$115
AstraZeneca Pharmaceuticals LP
$94
Impulse Dynamics (USA) Inc.
$83
Novo Nordisk Inc
$66
E.R. Squibb & Sons, L.L.C.
$63
Abbott Laboratories
$61
HEARTFLOW, INC.
$59
SANOFI-AVENTIS U.S. LLC
$54
Lexicon Pharmaceuticals, Inc.
$52
Actelion Pharmaceuticals US, Inc.
$42
PFIZER INC.
$41
Azurity Pharmaceuticals, Inc.
$36
Boehringer Ingelheim Pharmaceuticals, Inc.
$36
SCPHARMACEUTICALS INC.
$33
Edwards Lifesciences Corporation
$31
GENZYME CORPORATION
$29
CVRx, Inc.
$24
Alnylam Pharmaceuticals Inc.
$23
AGEPHA Pharma FZ LLC
$21
GE HEALTHCARE
$19
Kestra Medical Technology Services, Inc.
$17
Top 3 companies account for 29.3% of 2024 payments
All-time payments by company (2018-2024) ›
SANOFI-AVENTIS U.S. LLC
$1,493
Janssen Pharmaceuticals, Inc
$1,371
Novartis Pharmaceuticals Corporation
$1,204
Amgen Inc.
$1,026
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$777
PFIZER INC.
$539
AstraZeneca Pharmaceuticals LP
$523
Merck Sharp & Dohme LLC
$499
E.R. Squibb & Sons, L.L.C.
$453
Boehringer Ingelheim Pharmaceuticals, Inc.
$410
Abbott Laboratories
$376
iRhythm Technologies, Inc.
$335
Boston Scientific Corporation
$310
Impulse Dynamics (USA) Inc.
$281
Actelion Pharmaceuticals US, Inc.
$241
Medtronic, Inc.
$176
Astellas Pharma US Inc
$136
Kiniksa Pharmaceuticals International, plc
$131
Amarin Pharma Inc.
$118
Esperion Therapeutics, Inc.
$87
CARDIVA MEDICAL, INC.
$82
Lexicon Pharmaceuticals, Inc.
$74
Allergan Inc.
$73
SCPHARMACEUTICALS INC.
$67
AngioDynamics, Inc.
$66
Novo Nordisk Inc
$66
ARBOR PHARMACEUTICALS, INC.
$63
HeartFlow, Inc.
$61
Edwards Lifesciences Corporation
$60
HEARTFLOW, INC.
$59
ARALEZ PHARMACEUTICALS US INC.
$56
Merck Sharp & Dohme Corporation
$53
Alnylam Pharmaceuticals Inc.
$52
CVRx, Inc.
$51
Bayer Healthcare Pharmaceuticals Inc.
$49
Kowa Pharmaceuticals America, Inc.
$42
Azurity Pharmaceuticals, Inc.
$36
American Regent
$29
GENZYME CORPORATION
$29
Arbor Pharmaceuticals, Inc.
$28
Althera Pharmaceuticals LLC
$22
AGEPHA Pharma FZ LLC
$21
Medtronic Vascular, Inc.
$21
NOVARTIS PHARMACEUTICALS CORPORATION
$19
GE HEALTHCARE
$19
BOSTON SCIENTIFIC CORPORATION
$19
Kiniksa Pharmaceuticals, Ltd.
$19
Gilead Sciences, Inc.
$18
Bayer HealthCare Pharmaceuticals Inc.
$18
Kestra Medical Technology Services, Inc.
$17
InfoBionic, Inc
$17
Inspire Medical Systems, Inc.
$17
Preventice Services, LLC
$15
Bardy Diagnostics, Inc.
$14
Tactile Systems Technology Inc
$14
Top 3 companies account for 34.3% of all-time payments
Associated products mentioned in payments ›
Adempas · Arcalyst · Assure WCD · Assurity Pacemaker · Azure · BG Mini Plus · BRILINTA · BYSTOLIC · Barostim Neo System · BodyGuardian · CAMZYOS · CARDIOMEMS · CARDIVA VASCADE 5F VCS · CARDIVA VASCADE 6/7F VCS · CARDIVA VASCADE MVP VVCS 6-12F · CHANTIX · CONFIRM RX · COREVALVE EVOLUT R · Carnation Ambulatory Monitor · Confirm Rx · Corlanor · EDARBI · EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE (THV) · ELIQUIS · ENTRESTO · Edarbi · Edarbyclor · FABRAZYME · FARXIGA · FFRct · FLEXITOUCH · FUROSCIX · General - Therapies · HARMONY · INJECTAFER · INSPIRE · Inpefa · JARDIANCE · Kerendia · LEQVIO · LEXISCAN · LODOCO · LUX-Dx Insertable Cardiac Monitor · LifeVest · Livalo · MITRACLIP · MULTAQ · Merlin Connectivity and Remote · MoMe Kardia · NEXLETOL · ONPATTRO · OPSUMIT · OPSUMIT MACITENTAN · OPTIMIZER · Optimizer · PRALUENT · Pacemakers · Quadra Assura CRT Defibrillator · RESONATE · Repatha · Resolute · Roszet · Rybelsus · THORATEC HEARTMATE 3 LVAS IMPLANT KIT · UPTRAVI · VERQUVO · Vascepa · WATCHMAN · WATCHMAN Access System · WATCHMAN FLX · XARELTO · ZIO XT Patch · ZONTIVITY · Zio monitor
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Cardiologists in nearby ZIP areas
294
County median income
$113,409
Nearest hospital to ZIP centroid (approximate)
HOUSTON METHODIST SUGARLAND HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Smith is a clinical cardiology specialist, with above-average Medicare volume (top 14% in TX), with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Smith experienced with ekg interpretation and report?
Based on Medicare claims data, Dr. Smith performed 1,681 ekg interpretation and report services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Smith receive payments from pharmaceutical companies?
Yes. Dr. Smith received a total of $11,852 from 55 companies across 600 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Smith's costs compare to other cardiologists in Sugar Land?
Dr. Smith's average Medicare payment per service is $50. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Smith) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiologists in Sugar Land
Browse cardiologists in Sugar Land ranked by procedure volume and transparency data.
Highest volume
Top Cardiologists in TX
Cardiologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiologists in TX
Which TX cardiologists receive the most from drug and device companies.
By company
SANOFI-AVENTIS U.S. LLC Payments to Doctors
See all physicians who received payments from SANOFI-AVENTIS U.S. LLC.
By company
Janssen Pharmaceuticals, Inc Payments to Doctors
See all physicians who received payments from Janssen Pharmaceuticals, Inc.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology